CVR 38546880Private limited company (ApS)Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)FrederiksbergFounded 4 Apr 2017
Employees
11
CVR registry, Aug 2026
+1 (+10%) over 12 months
Revenue
45.1M
DKK, annual report 2025
Result
-12.3M
DKK, annual report 2025
Equity
15.3M
DKK, annual report 2025
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about Draupnir Bio ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexNovo Holdings A/SCVR 24257630, 20% to under 25% of capital and votes, since 23 Oct 2019
Coöperatieve Gilde Healthcare IV U.A.20% to under 25% of capital and votes, since 23 Oct 2019
and 3 moreAndrew Thomas Hotchkisssince 1 Jun 2021
CVR 2425763020% to under 25% of capital and votessince 23 Oct 2019
CVR 4347820610% to under 15% of capital and votessince 10 Jul 2024
20% to under 25% of capital and votessince 23 Oct 2019
10% to under 15% of capital and votessince 26 Mar 2024
20% to under 25% of capital and votessince 29 Jun 2026
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
CVR 385456635% to under 10% of capital and votes4 Apr 2017 to 18 Aug 2021
CVR 385458415% to under 10% of capital and votes4 Apr 2017 to 18 Aug 2021
CVR 385459065% to under 10% of capital and votes4 Apr 2017 to 18 Aug 2021
5% to under 10% of capital and votes14 Sep 2018 to 18 Aug 2021
5% to under 10% of capital and votes23 Oct 2019 to 10 Feb 2023
20% to under 25% of capital and votes23 Oct 2019 to 29 Jun 2026
CVR records founders at incorporation. It does not record whether they are alive or still involved.
4 Apr 2017 to 3 Nov 2026.
4 Apr 2017 to 3 Nov 2026.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | Not reported | Not reported | Not reported | Not reported | 45,120 |
| Operating profit | -71,752 | -45,037 | -46,436 | -46,149 | -9,518 |
| Result for the year | -67,044 | -39,890 | -41,166 | -40,314 | -12,310 |
| Equity | 53,466 | 18,566 | 29,386 | 27,633 | 15,256 |
| Total assets | 67,865 | 28,383 | 36,192 | 35,033 | 39,072 |
| Credit metrics (Dandex calculations) | |||||
| EBIT margin (overskudsgrad) | Not reported | Not reported | Not reported | Not reported | -21.1% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | Not reportednote 1 | -8,441 | -19,112 | -22,805 | -33,902 |
| ROIC (afkast af investeret kapital) | Not reportednote 1 | -367.8%note 2 | -355.1%note 2 | -476.7%note 2 | n.m.note 3 |
| Capex (investeringer i anlægsaktiver) | 10,773 | 435 | 0 | 137 | 0 |
| Capex % of sales (investeringer i procent af omsætningen) | Not reported | Not reported | Not reported | Not reported | 0% |
DKK thousands. Annual reports via XBRL. Large listed filers report IFRS figures in an ESEF report, for the group where there is one.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions. Group figures (koncern).
Annual report 2025
1 Jan 2025 to 31 Dec 2025, published 4 Jun 2026
Annual report 2024
1 Jan 2024 to 31 Dec 2024, published 27 Jun 2025
Annual report 2023
1 Jan 2023 to 31 Dec 2023, published 15 May 2024
Annual report 2022
1 Jan 2022 to 31 Dec 2022, published 12 Jun 2023
Annual report 2021
1 Jan 2021 to 31 Dec 2021, published 10 Jun 2022
Draupnir Bio ApS has changed ownership. A new strategy and new needs can be expected.
Signal, a Dandex estimate. Lapses 11 Nov 2026.
2 registered in CVR.
P-number 1027036437Palle Juul-Jensens Boulevard 82, 8200 Aarhus N
P-number 1022336491Nordre Fasanvej 215, 2000 Frederiksberg
No other current company drawn.
No other current company drawn.
No other current company drawn.
No other current company drawn.
